ContractConvertible Debenture • May 15th, 2017 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • Florida
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.
FIRST AMENDMENT TO CONVERTIBLE DEBENTUREConvertible Debenture Amendment • May 15th, 2017 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products
This First Amendment to the Convertible Debenture (the “First Amendment”) is entered into as of May 11, 2017 by and among Tauriga Sciences, Inc., a Florida corporation (the “Company”) and Group 10 Holdings LLC (“Holder”) or its registered assigns or successor in interest. The Company and Holder each referred to herein as a “Party” or collectively as the “Parties”.
